Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Total Current Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Current Liabilities ₹6,507 Cr₹5,664 Cr₹2,120 Cr₹1,863 Cr₹2,623 Cr

What is the latest Total Current Liabilities ratio of MANKIND PHARMA ?

The latest Total Current Liabilities ratio of MANKIND PHARMA is ₹6,507 Cr based on Mar2026 Consolidated results.
Year Total Current Liabilities
Mar2026₹6,507 Cr
Mar2025₹5,664 Cr
Mar2024₹2,120 Cr
Mar2023₹1,863 Cr
Mar2022₹2,623 Cr

How is Total Current Liabilities of MANKIND PHARMA Trending?

Years Total Current Liabilities % Change
Mar2026 ₹6,507 Cr
14.90
Mar2025 ₹5,664 Cr
167.18
Mar2024 ₹2,120 Cr
13.77
Mar2023 ₹1,863 Cr
-28.98
Mar2022 ₹2,623 Cr -

Compare Total Current Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹93,003.5 Cr -4.9% -1.9% -6.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr -1.4% -6.5% 5.5% Stock Analytics
DIVIS LABORATORIES ₹241,311.0 Cr -2% -2.7% 40.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,079.0 Cr -1.8% -7% 29.6% Stock Analytics
CIPLA ₹107,528.0 Cr 0.1% -3% -15.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,667.0 Cr 0.2% 6% -2.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-4.9%

-1.9%

-6.8%

SENSEX

2.7%

-0.7%

-10.5%


You may also like the below Video Courses